Tech-savvy parents to be are using IVF and screening embryos to build families in ways that were unimaginable a few short ...

Obesity is a well-established risk factor for a broad spectrum of chronic diseases, including cardiovascular disease, diabetes, cancer, and liver disease.

Since the landmark approvals of lecanemab and donanemab, anti-amyloid immunotherapy has marked a paradigm shift in ...

Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease, affecting up to one in three people in the general population, with an ...

An adjuvant is one of those key components. Added to a vaccine, an adjuvant can enhance the body's immune response, making ...

Lung cancer is no longer solely a smoker's disease, with air pollution emerging as a significant risk factor affecting ...

For almost 80 years, the US Centers for Disease Control and Prevention (CDC) has been the nation's immune system, detecting threats early, coordinating rapid responses, and safeguarding population ...

Rising healthcare investments in regions like the U.S., Europe, and Japan, alongside enhanced diagnostic tools, support market dynamics. Despite challenges such as high treatment costs in low-income ...

New tools that create ultra-precise maps of our tissues are transforming our ability to diagnose and cure once-fatal ...

The intersection of climate change with chronic disease and healthcare infrastructure creates a critical and underreported ...

Accelerometer data from nearly 95,000 adults show that higher daily step counts predict lower short-term Parkinson’s disease ...

Scientists are increasingly clear that the most serious threats to human health are no longer confined to hospital wards or ...